• 1. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 2. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 3. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 4. Exciton manipulation in rippled transition metal dichalcogenides?
  Chen Long,Ying Dai,Jianwei Li,Hao Jin Nanoscale, 2020,12, 21124-21130
• 5. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles

Professional Introduction to 2(3H)-Thiazolethione,5-ethyl- (CAS No. 371120-77-3)

2(3H)-Thiazolethione,5-ethyl-, identified by the Chemical Abstracts Service Number (CAS No.) 371120-77-3, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and bioorganic synthesis. This compound belongs to the thiazolethione class, a structural motif known for its broad spectrum of biological activities and utility in medicinal chemistry. The presence of an ethyl substituent at the 5-position of the thiazole ring introduces unique electronic and steric properties, making it a versatile scaffold for drug discovery and development.

The thiazolethione core is a sulfur-containing heterocycle that plays a pivotal role in medicinal chemistry due to its ability to interact with biological targets such as enzymes and receptors. The sulfur atom in thiazolethiones can participate in hydrogen bonding, metal coordination, and redox reactions, which are crucial for the design of bioactive molecules. The ethyl group at the 5-position further modulates the reactivity and pharmacokinetic properties of the compound, influencing its solubility, metabolic stability, and binding affinity.

In recent years, there has been a surge in research focused on developing novel thiazole derivatives as potential therapeutic agents. Studies have demonstrated that 2(3H)-Thiazolethione,5-ethyl- exhibits promising biological activities, including antimicrobial, anti-inflammatory, and anticancer properties. These findings are supported by both in vitro and in vivo experimental data, which highlight the compound's ability to modulate key cellular pathways involved in disease progression.

One of the most intriguing aspects of 2(3H)-Thiazolethione,5-ethyl- is its potential as a lead compound for the development of targeted therapies. Researchers have leveraged computational chemistry and structure-activity relationship (SAR) studies to optimize its pharmacological profile. For instance, modifications at the 3-position of the thiazole ring have been explored to enhance binding interactions with specific protein targets. These efforts have led to the identification of analogs with improved potency and selectivity.

The pharmacological significance of thiazolethiones has been further underscored by their role in inhibiting enzymes such as thioredoxin reductase and cathepsin L. These enzymes are implicated in various pathological conditions, including cancer and neurodegenerative diseases. The ethyl-substituted derivative (CAS No. 371120-77-3) has been shown to exhibit inhibitory activity against these enzymes, suggesting its therapeutic potential in treating related disorders.

Moreover, synthetic methodologies for accessing 2(3H)-Thiazolethione,5-ethyl- have been refined to ensure high yield and purity. Modern synthetic approaches often involve transition-metal-catalyzed cross-coupling reactions and palladium-mediated transformations, which allow for efficient construction of complex thiazole derivatives. These advances have enabled researchers to explore diverse structural modifications and evaluate their impact on biological activity.

The integration of computational modeling with experimental techniques has been instrumental in understanding the mechanism of action of 2(3H)-Thiazolethione,5-ethyl-. Molecular docking studies have revealed that this compound interacts with target proteins through hydrophobic and polar interactions, providing insights into its binding mode. Such information is critical for designing next-generation drugs with enhanced efficacy and reduced side effects.

Recent preclinical studies have highlighted the potential of thiazole derivatives as antitumor agents. The ethyl-substituted derivative (CAS No. 371120-77-3) has demonstrated ability to induce apoptosis in cancer cells by disrupting mitochondrial function and inhibiting pro-survival signaling pathways. These findings align with emerging evidence suggesting that thiazolethiones can selectively target malignant cells while sparing healthy tissues.

The versatility of 2(3H)-Thiazolethione,5-ethyl- as a pharmacophore is further exemplified by its incorporation into multimodal therapeutic strategies. By combining it with other bioactive molecules or nanoparticles, researchers aim to develop synergistic approaches for treating complex diseases such as cancer and inflammation-related disorders. Such combinatorial therapies hold promise for overcoming drug resistance and improving patient outcomes.

In conclusion,2(3H)-Thiazolethione,5-ethyl- (CAS No. 371120-77-3) represents a significant advancement in pharmaceutical chemistry due to its unique structural features and broad spectrum of biological activities. Ongoing research continues to uncover new applications for this compound, reinforcing its importance as a lead molecule in drug discovery efforts aimed at addressing unmet medical needs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)